Re: CSM members' declarations of interest, 1996
| Number and percentage of CSM members who disclosed, in 1996: | Personal interests with any company marketing SSRIs (listed on left) | Personal/non-personal interests with company marketing SSRIs | Either personal or non-personal interests with at least one company |
| SmithKline Beecham | 4/30 13% | 9/30 30% | 12/30 40% |
| Eli Lilly | 4/30 13% | 5/30 17% | 7/30 23% |
| Pfizer | 0/30 | 10/30 33% | 10/30 33% |
| Bristol Myers Squibb | 2/30 7% | 5/30 17% | 7/30 23% |
| Wyeth | 2/30 7% | 3/30 10% | 5/30 17% |
| Lundbeck | 1/30 3% | 0/30 | 1/30 3% |
| Solvay | 0/30 | 1/30 3% | 1/30 3% |